Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Esmya
Connect with this vendor - Learn about this product

Ulipristal Acetate (Esmya)

Esmya is used to treat moderate to severe symptoms of uterine fibroids, which are noncancerous (benign) tumors of the womb (uterus), in adult women who have not yet reached the menopause.It is used in women before they undergo surgery on their fibroids and can also be used long-term but with treatment breaks in other women.

Each tablet contains 5mg of Ulipristalacetat

  • Trade name: ​Esmya 5mg
  • Manufacturer: ​Gedeon Richter Ltd.
  • Presentation: Tablet
  • Strength:  5mg  
  • Pack Size: 28 Tablets
  • Pack Insert: Yes
  • National Drug Code: No
  • Marketing Authorization Holder: Gedeon Richter Ltd.
  • Manufacturing License: EU/1/12/750/001